Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......
In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN......
A day after its plant was inspected by Indian drug regulatory bodies over allegations that its eye drop was linked to vision loss in the United States, Tamil Nadu-based Global Pharma Healthcare has......
The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......
In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the......
India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.......
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.......
'If people have to build new facilities, and by the time they are operational, it will be time for a new President in the US.' Photograph: Amit Dave/Reuters After registering a net profit of Rs......
Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse......
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......